Back to
PANAGORA ASSET MANAGEMENT INC
HALO
Showing 0 of 19 quarters
Position history for
PANAGORA ASSET MANAGEMENT INC's holdings in Halozyme Therapeutics, Inc.
No. PanAgora Asset Management exited its HALO (Halozyme Therapeutics) position in Q2 2023. Its Q1 2023 13F listed 17,755 shares worth $678,063. PanAgora Asset Management already held HALO in its Q4 2018 13F, the earliest on record, and held it in 18 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.